+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Controlled Release Drug Delivery Market Size, Share & Trends Analysis Report by Technology (Micro Encapsulation, Targeted Delivery), by Release Mechanism, by Application, by Region, and Segment Forecasts, 2020 - 2027

  • ID: 4538763
  • Report
  • March 2020
  • Region: Global
  • 120 pages
  • Grand View Research
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Alkermes plc
  • Aradigm Corporation
  • Capsugel
  • Coating Place, Inc.
  • Depomed, Inc.
  • Merck and Co., Inc.
  • MORE
The global controlled release drug delivery market size is estimated to reach USD 69.8 billion by 2027 registering a CAGR of 7.8% during the forecast period. The benefits associated with controlled release drug delivery systems, such as increased therapeutic efficacy, less side effects, and low treatment cost are the factors driving the market growth.

These technologies offer various benefits over traditional delivery forms, such as reduced dosage and dosage frequency, enhanced patient compliance, less gastrointestinal side effects, uniform drug effect, improved drug efficacy and safety, and reduced fluctuation of plasma drug levels.

Presence of multiple in-vivo biological barriers that affects the absorption, bioavailability, and stability of the drug has open wide horizon for the controlled release drug delivery products. For instance, controlled release drug delivery system has enabled delivery of even large and complex molecules such as DNA/RNA, proteins and polypeptides. Additionally, the rising awareness among healthcare professionals, regarding the advantage of controlled release drug delivery systems over conventional systems is expected to drive the demand for the market in long run.

Rapidly increasing geriatric and pediatric population is one of the major factors fueling the demand for controlled release drug delivery systems, due to high cases prescription non-adherence in this age-group. Innovations in various drug delivery systems has been providing geriatric and pediatric population with easy solutions, which are further propelling the market. Controlled release of drug delivery systems can be altered according to required dosage over a specific period of time.

Further key findings from the report suggest:
  • Based on application, oral controlled release systems held the largest market share in 2019 owing to increasing usage and ease of convenience offered for administration of medication
  • Targeted drug delivery is poised to be the fastest growing technology segment during the forecast period owing to various benefits of the technology, such as increased safety and therapeutic efficacy
  • Osmotic delivery is projected to witness the fastest CAGR in the activation modulation drug delivery systems during the forecast period, due to the ability of this release mechanism to not be affected by various factors, such as pH, food consumption, and gastrointestinal motility
  • North America held the largest market share in 2019 owing to the presence of developed healthcare infrastructure facilities, increasing R&D activities and existence of major market players
  • Asia Pacific is expected to post the highest CAGR during the forecast period owing to rising investments by dominant players in the region along with developments in the of pharmaceutical industry in emerging countries, such as India and China
  • Some of the prominent companies operating in the controlled release drug delivery market are Orbis Biosciences, Inc., Merck and Co., Inc., Alkermes plc, Johnson and Johnson, Coating Place, Inc., Corium International, Inc., Depomed, Inc., Pfizer, Inc, Aradigm Corporation, and Capsugel

Please note: This product will be delivered within 48 business hours after receipt of order.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Alkermes plc
  • Aradigm Corporation
  • Capsugel
  • Coating Place, Inc.
  • Depomed, Inc.
  • Merck and Co., Inc.
  • MORE
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Technology
1.1.2. Release mechanism
1.1.3. Application
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. Internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Technology outlook
2.2.2. Release mechanism outlook
2.2.3. Regional outlook
2.3. Competitive Insights

Chapter 3. Controlled release drug delivery Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Increase in need for controlled release dosage forms for pediatric and geriatric population
3.4.1.2. Increased compliance due to nature of dosage forms
3.4.2. Market restraint analysis
3.4.2.1. Limited amount of controlled release dosage forms is accepTable for usage in pediatric conditions
3.4.2.2. Need for high dose of active pharmaceutical ingredient
3.5. Controlled Release Drug Delivery Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies

Chapter 4. Global controlled release drug delivery Market: Technology Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Wurster technique
4.1.2. Coacervation
4.1.3. Micro encapsulation
4.1.4. Implants
4.1.5. Transdermal
4.1.6. Targeted delivery
4.1.7. Others
4.2. controlled release drug delivery Market Share, 2019 & 2027
4.3. Segment Dashboard
4.4. Global controlled release drug delivery Market by Technology Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following
4.5.1. Wurster technique
4.5.1.1. Wurster technique controlled release drug delivery market, 2016 - 2027 (USD Million)
4.5.2. Coacervation
4.5.2.1. Coacervation controlled release drug delivery market, 2016 - 2027 (USD Million)
4.5.3. Micro Encapsulation
4.5.3.1. Micro encapsulation controlled release drug delivery market, 2016 - 2027 (USD Million)
4.5.4. Implants
4.5.4.1. Implants controlled release drug delivery market, 2016 - 2027 (USD Million)
4.5.5. Transdermal
4.5.5.1. Transdermal controlled release drug delivery market, 2016 - 2027 (USD Million)
4.5.6. Targeted delivery
4.5.6.1. Targeted delivery controlled release drug delivery market, 2016 - 2027 (USD Million)
4.5.7. Others
4.5.7.1. Others controlled release drug delivery market, 2016 - 2027 (USD Million)

Chapter 5. Global controlled release drug delivery Market: Release Mechanism Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Polymer Based Systems
5.1.2. Micro Reservoir Partition Controlled Drug Delivery Systems
5.1.3. Feedback Regulated Drug Delivery Systems
5.1.4. Activation-modulated Drug Delivery Systems
5.1.4.1. Osmotic Pressure Activated
5.1.4.2. Hydrodynamic Pressure Activated
5.1.4.3. Vapor Pressure Activated
5.1.4.4. Mechanically Activated
5.1.4.5. Magnetically Activated
5.1.5. Chemically Activated
5.1.5.1. pH Activated
5.1.5.2. Hydrolysis Activated
5.1.5.3. Enzyme Activated
5.2. controlled release drug delivery Market Share, 2019 & 2027
5.3. Segment Dashboard
5.4. Global controlled release drug delivery Market by Release Mechanism Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following
5.5.1. Polymer based systems
5.5.1.1. Polymer based systems controlled release drug delivery market, 2016 - 2027 (USD Million)
5.5.2. Micro reservoir partition controlled drug delivery systems
5.5.2.1. Micro reservoir partition controlled drug delivery systems market, 2016 - 2027 (USD Million)
5.5.3. Feedback regulated drug delivery systems
5.5.3.1. Feedback regulated drug delivery systems market, 2016 - 2027 (USD Million)
5.5.4. Activation-modulated drug delivery systems
5.5.4.1. Activation-modulated drug delivery systems market, 2016 - 2027 (USD Million)
5.5.4.2. Osmotic pressure activated systems market, 2016 - 2027 (USD Million)
5.5.4.3. Hydrodynamic pressure activated systems market, 2016 - 2027 (USD Million)
5.5.4.4. Vapor pressure activated systems market, 2016 - 2027 (USD Million)
5.5.4.5. Mechanically activated systems market, 2016 - 2027 (USD Million)
5.5.4.6. Magnetically activated systems market, 2016 - 2027 (USD Million)
5.5.5. Chemically activated
5.5.5.1. pH activated controlled release drug delivery market, 2016 - 2027 (USD Million)
5.5.5.2. Hydrolysis activated controlled release drug delivery market, 2016 - 2027 (USD Million)
5.5.5.3. Enzyme activated controlled release drug delivery market, 2016 - 2027 (USD Million)

Chapter 6. Global controlled release drug delivery Market: Application Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Metered Dose Inhalers
6.1.2. InjecTable
6.1.3. Transdermal and Ocular Patches
6.1.4. Infusion Pumps
6.1.5. Oral Controlled-drug delivery Systems
6.1.6. Drug Eluting Stents
6.2. controlled release drug delivery Market Share, 2019 & 2027
6.3. Segment Dashboard
6.4. Global controlled release drug delivery Market by Application Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following
6.5.1. Metered dose inhalers
6.5.1.1. Metered dose inhaler controlled release drug delivery market, 2016 - 2027 (USD Million)
6.5.2. InjecTable
6.5.2.1. InjecTable controlled release drug delivery market, 2016 - 2027 (USD Million)
6.5.3. Transdermal and ocular patches
6.5.3.1. Transdermal and ocular patches controlled release drug delivery market, 2016 - 2027 (USD Million)
6.5.4. Infusion Pumps
6.5.4.1. Infusion pumps controlled release drug delivery market, 2016 - 2027 (USD Million)
6.5.5. Oral controlled release drug delivery system
6.5.5.1. Oral controlled release drug delivery market, 2016 - 2027 (USD Million)
6.5.6. Drug eluting stents
6.5.6.1. Drug eluting stents controlled release drug delivery market, 2016 - 2027 (USD Million)

Chapter 7. Global controlled release drug delivery Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2019 & 2027
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Regional Market Share and Leading Players, 2019
7.4.1. North America
7.4.2. Europe
7.4.3. Asia Pacific
7.4.4. Latin America
7.4.5. Middle East and Africa
7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
7.5.1. North America
7.5.2. Europe
7.5.3. Asia Pacific
7.5.4. Latin America
7.5.5. Middle East and Africa
7.6. Market Size, & Forecasts, Volume and Trend Analysis, 2019 to 2027:
7.7. North America
7.7.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.7.2. U.S.
7.7.2.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.7.3. Canada
7.7.3.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.8. Europe
7.8.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.8.2. U.K.
7.8.2.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.8.3. Germany
7.8.3.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.8.4. France
7.8.4.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.8.5. Italy
7.8.5.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.8.6. Spain
7.8.6.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.8.7. Russia
7.8.7.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.8.8. Switzerland
7.8.8.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.8.9. The Netherland
7.8.9.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.8.10. Sweden
7.8.10.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.8.11. Belgium
7.8.11.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.8.12. Others
7.8.12.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.9. Asia Pacific
7.9.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.9.2. Japan
7.9.2.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.9.3. China
7.9.3.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.9.4. India
7.9.4.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.9.5. South Korea
7.9.5.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.9.6. Thailand
7.9.6.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.9.7. Indonesia
7.9.7.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.9.8. Philippines
7.9.8.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.9.9. Vietnam
7.9.9.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.9.10. Malaysia
7.9.10.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.9.11. Singapore
7.9.11.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.9.12. Others
7.9.12.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.10. Latin America
7.10.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.10.2. Brazil
7.10.2.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.10.3. Mexico
7.10.3.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.10.4. Argentina
7.10.4.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.10.5. Colombia
7.10.5.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.10.6. Chile
7.10.6.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.10.7. Others
7.10.7.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.11. MEA
7.11.1. South Africa
7.11.1.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.11.2. Saudi Arabia
7.11.2.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.11.3. UAE
7.11.3.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.11.4. Kuwait
7.11.4.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.11.5. Israel
7.11.5.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.11.6. Others
7.11.6.1. Market estimates and forecast, 2016 - 2027 (USD Million)

Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Innovators
8.2.2. Market Leaders
8.2.3. Emerging Players
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2019
8.4. Public Companies
8.4.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
8.4.2. Company market share/ranking, by region
8.4.3. Competitive dashboard analysis
8.4.3.1. Market differentiators
8.4.3.2. Synergy analysis: major deals and strategic alliances
8.5. Private Companies
8.5.1. List of key emerging companies/technology disruptors/innovators
8.5.2. Funding outlook
8.5.3. Regional network map
8.5.4. Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)
8.5.5. Supplier ranking
8.5.6. Key company profiled
8.5.7. Depomed, Inc.
8.5.7.1. Company overview
8.5.7.2. Financial performance
8.5.7.3. Product benchmarking
8.5.7.4. Strategic initiatives
8.5.8. Coating Place, Inc.
8.5.8.1. Company overview
8.5.8.2. Financial performance
8.5.8.3. Product benchmarking
8.5.8.4. Strategic initiatives
8.5.9. Corium International, Inc.
8.5.9.1. Company overview
8.5.9.2. Financial performance
8.5.9.3. Product benchmarking
8.5.9.4. Strategic initiatives
8.5.10. Johnson and Johnson Services, Inc.
8.5.10.1. Company overview
8.5.10.2. Financial performance
8.5.10.3. Product benchmarking
8.5.10.4. Strategic Initiative
8.5.11. Alkermes plc
8.5.11.1. Company overview
8.5.11.2. Financial performance
8.5.11.3. Product benchmarking
8.5.11.4. Strategic initiatives
8.5.12. Pfizer, Inc.
8.5.12.1. Company overview
8.5.12.2. Financial performance
8.5.12.3. Product benchmarking
8.5.12.4. Strategic initiatives
8.5.13. Orbis Biosciences, Inc.
8.5.13.1. Company overview
8.5.13.2. Financial performance
8.5.13.3. Product benchmarking
8.5.13.4. Strategic initiatives
8.5.14. Capsugel
8.5.14.1. Company overview
8.5.14.2. Financial performance
8.5.14.3. Product benchmarking
8.5.14.4. Strategic initiatives
8.5.15. Merck and Co., Inc.
8.5.15.1. Company overview
8.5.15.2. Financial performance
8.5.15.3. Product benchmarking
8.5.15.4. Strategic initiatives
8.5.16. Aradigm Corporation
8.5.16.1. Company overview
8.5.16.2. Financial performance
8.5.16.3. Product benchmarking
8.5.16.4. Strategic initiatives
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Depomed, Inc.
  • Coating Place, Inc.
  • Corium International, Inc.
  • Johnson and Johnson Services, Inc.
  • Alkermes plc
  • Pfizer, Inc.
  • Orbis Biosciences, Inc.
  • Capsugel
  • Merck and Co., Inc.
  • Aradigm Corporation
Note: Product cover images may vary from those shown
Adroll
adroll